Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
Tacrolimus or its derivativesPDL I DEC / 13
Tadalafil or its saltsPDL I DEC / 13
TalbutalC2 I JUN / 02
Taliglucerase alfaPDL I JUN / 14
Tamoxifen or its saltsPDL I DEC / 13
Tamsulosin or its saltsPDL I DEC / 13
TapentadolN (3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]-phenol), its salts, derivatives and isomers and salts of derivatives and isomers I JAN / 16
TazarotenePDL I DEC / 13
Tazobactam or its salts or derivativesPDL I DEC / 13
Tedizolid or its salts or derivativesPDL

including but not limited to Tedizolid phosphate

I MAY / 15
TeduglutidePDL I OCT / 15
TeflubenzuronPDL I DEC / 13
Tegaserod or its saltsPDL I DEC / 13
Telaprevir or its derivativesPDL I DEC / 13
TelbivudinePDL I DEC / 13
Telmisartan or its salts or derivativesPDL I DEC / 13
Telotristat or its salts or derivativesPDL I NOV / 18
Temazepam and its saltsTS I SEP / 98
Temozolomide or its saltsPDL I DEC / 13
TeniposidePDL I DEC / 13
Tenofovir or its salts or derivativesPDL

Including but not limited to: tenofovir disoproxil, tenofovir alafenamide

I DEC / 13
Tenoxicam or its saltsPDL I DEC / 13
Tepoxalin or its derivativesPDL I DEC / 13
Terazosin or its saltsPDL I DEC / 13
Terbinafine or its saltsPDL I DEC / 13
Terbutaline or its saltsPDL I DEC / 13
Terconazole or its saltsPDL I DEC / 13
Terfenadine or its saltsPDL I DEC / 13
Teriparatide or its saltsPDL I DEC / 13
Terlipressin or its saltsPDL I DEC / 13
Tesamorelin or its salts or derivativesPDL I APR / 14
TestosteroneC3 I JUN / 02
Tetanus immune globulin I FEB / 02
Tetanus toxoid II DEC / 98
Tetrabenazine or its saltsPDL I DEC / 13
TetracainePDL

when in a preparation containing an equal amount of lidocaine and recommended for topical use on the skin, in concentrations of 7% or higher

I FEB / 14
Tetracaine and its salts

for ophthalmic or parenteral use

II SEP / 98
Tetracaine and its salts for topical use on mucous membranes, except lozenges III SEP / 98
Tetracycline or its salts or derivativesPDL I DEC / 18
Tetrahydrozoline in nasal preparations for pediatric use II SEP / 98
Tetrahydrozoline. for ophthalmic use and in nasal preparations for adults U
TetrazepamTS I JUN / 02
Tezacaftor or its saltsPDL I JUL / 18
ThalidomidePDL I DEC / 13
ThebaconN I JUN / 02
Thebaine (paramorphine)N I JUN / 02
Theophylline or its saltsPDL I DEC / 13
ThiabendazolePDL

For human use

I DEC / 13
ThialbarbitalC2 I JUN / 02
ThiamylalC2 I JUN / 02
Thiethylperazine or its saltsPDL I DEC / 13
Thiobarbituric AcidC2 I JUN / 02
ThiocarlidePDL I DEC / 13
ThiofentanylN I JUN / 02
ThioguaninePDL I DEC / 13
ThiopentalC2 I JUN / 02
Thiopropazate or its saltsPDL I DEC / 13
Thioproperazine or its saltsPDL I DEC / 13
Thioridazine or its saltsPDL I DEC / 13
ThiotepaPDL I DEC / 13
Thiothixene or its saltsPDL I DEC / 13
Thiouracil or its derivativesPDL I DEC / 13
Thrombin II SEP / 98
Thyroglobulin II SEP / 98
ThyroidPDL

For human use

I DEC / 13
Thyrotropin II SEP / 98
Thyrotropin alfaPDL I DEC / 13
Thyroxin or its saltsPDL

Including but not limited to Levothyroxine sodium

I DEC / 13
Tiamulin or its saltsPDL

For veterinary use, including but not limited to: Tiamulin fumarate

I DEC / 18
Tiaprofenic acid or its saltsPDL I DEC / 13
TiboloneC3 I JUN / 02
Ticagrelor or its derivativesPDL I DEC / 13
Ticarcillin or its salts or derivativesPDL

For veterinary use

I DEC / 13
Ticlopidine or its saltsPDL I DEC / 13
TigecyclinePDL I DEC / 13
Tilidine and its salts, derivatives and salts of derivativesN I JUN / 02
Tiludronic acid or its saltsPDL I DEC / 13
Timolol or its saltsPDL I DEC / 13
TinidazolePDL I DEC / 13
Tinzaparin or its saltsPDL I DEC / 13
Tioconazole and its salts.. in preparations for intra-vaginal use III OCT / 98
Tioconazole and its salts... in preparations for topical use U OCT / 98
Tioconazole or its saltsPDL

For human use, except in preparations for topical or vaginal use 

I DEC / 13
TiomesteroneC3 I JUN / 02
Tiotropium bromidePDL I DEC / 13
Tipiracil or its saltsPDL I MAR / 18
Tipranavir or its saltsPDL I DEC / 13
Tirofiban or its salts or derivativesPDL I DEC / 13
TisagenlecleucelPDL I OCT / 18
Tizanidine or its saltsPDL I DEC / 13
Tobramycin or its salts or derivativesPDL I DEC / 13
Tocainide or its saltsPDL I DEC / 13
Toceranib or its saltsPDL I DEC / 13
TocilizumabPDL I DEC / 13
Tofacitinib or its saltsPDL I APR / 14
TolazamidePDL I DEC / 13
Tolazoline or its saltsPDL I DEC / 13
TolbutamidePDL I DEC / 13
TolcaponePDL I DEC / 13
Tolfenamic acid or its salts or derivativesPDL I DEC / 13

159 result(s)


Footnotes

  • C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations
  • C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
  • C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
  • C4: drug is in the Controlled Drugs and Substances Act
  • C5: drug is in the Regulations Under CDSA
  • CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
  • CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
  • CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
  • CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
  • F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
  • F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
  • FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
  • N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
  • NR: drug has not been reviewed by NDSAC
  • PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
  • R: drug is in Part J of the Food and Drugs Act and listed in the Controlled Drugs and Substances Act
  • TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
  • U: drug has been reviewed by NDSAC and is unscheduled